1.ELISA detection of vivax malaria with recombinant multiple stage-specific antigens and its application to survey of residents in endemic areas.
Sera KIM ; Hye Jin AHN ; Tong Soo KIM ; Ho Woo NAM
The Korean Journal of Parasitology 2003;41(4):203-207
An ELISA was developed for the diagnosis of vivax malaria using multiple stage-specific recombinant antigens of Plasmodium vivax. The DNA from the whole blood of a malaria patient was used as template to amplify the coding regions for the antigenic domains of circumsporozoite protein (CSP-1), merozoite surface protein (MSP-1), apical merozoite antigen (AMA-1), serine repeat antigen (SERA), and exported antigen (EXP-1). Each amplified DNA fragment was inserted into pQE30 plasmid to induce the expression of His-tagged protein in Escherichia coli (M15 strain) by IPTG. His-tagged proteins were purified by Ni-NTA metal-affinity chromatography and used as antigens for ELISA with patient sera that were confirmed previously by blood smear examinations. When applied to patient sera, 122 (80.3%) out of 152 vivax malaria cases reacted to at least one antigen, while no reactions were observed with 128 uninfected serum samples. We applied this ELISA to the screening of 3, 262 civilian residents in endemic regions near the DMZ, which resulted in 236 positively detected (7.2%) cases. This method can be applied to serological diagnosis and mass screening in endemic regions, or can be used as a safety test for transfusion blood in endemic areas.
Animals
;
Antibodies, Protozoan/*blood
;
Antigens, Protozoan/genetics/*immunology
;
*Endemic Diseases
;
Enzyme-Linked Immunosorbent Assay/methods
;
Humans
;
Life Cycle Stages
;
Malaria, Vivax/*diagnosis/epidemiology/parasitology
;
Mass Screening
;
Plasmodium vivax/*growth & development/immunology
;
Recombinant Proteins/*immunology
;
Serologic Tests
2.Evaluation of Rapid Diagnostics for Plasmodium falciparum and P. vivax in Mae Sot Malaria Endemic Area, Thailand.
Wanna CHAIJAROENKUL ; Thanee WONGCHAI ; Ronnatrai RUANGWEERAYUT ; Kesara NA-BANGCHANG
The Korean Journal of Parasitology 2011;49(1):33-38
Prompt and accurate diagnosis of malaria is the key to prevent disease morbidity and mortality. This study was carried out to evaluate diagnostic performance of 3 commercial rapid detection tests (RDTs), i.e., Malaria Antigen Pf/Pantrade mark, Malaria Ag-Pftrade mark, and Malaria Ag-Pvtrade mark tests, in comparison with the microscopic and PCR methods. A total of 460 blood samples microscopically positive for Plasmodium falciparum (211 samples), P. vivax (218), mixed with P. falciparum and P. vivax (30), or P. ovale (1), and 124 samples of healthy subjects or patients with other fever-related infections, were collected. The sensitivities of Malaria Ag-Pftrade mark and Malaria Antigen Pf/Pantrade mark compared with the microscopic method for P. falciparum or P. vivax detection were 97.6% and 99.0%, or 98.6% and 99.0%, respectively. The specificities of Malaria Ag-Pftrade mark, Malaria Ag-Pvtrade mark, and Malaria Antigen Pf/Pantrade mark were 93.3%, 98.8%, and 94.4%, respectively. The sensitivities of Malaria Ag-Pftrade mark, Malaria Antigen Pf/Pantrade mark, and microscopic method, when PCR was used as a reference method for P. falciparum or P. vivax detection were 91.8%, 100%, and 96.7%, or 91.9%, 92.6%, and 97.3%, respectively. The specificities of Malaria Ag-Pftrade mark, Malaria Ag-Pvtrade mark, Malaria Antigen Pf/Pantrade mark, and microscopic method were 66.2%, 92.7%, 73.9%, and 78.2%, respectively. Results indicated that the diagnostic performances of all the commercial RDTs are satisfactory for application to malaria diagnosis.
Antigens, Protozoan/blood
;
Cross-Sectional Studies
;
*Diagnostic Techniques and Procedures/instrumentation
;
Endemic Diseases/statistics & numerical data
;
Humans
;
Malaria/*diagnosis/epidemiology/parasitology
;
Malaria, Vivax
;
Plasmodium falciparum/genetics/immunology/*isolation & purification
;
Reagent Kits, Diagnostic
;
Thailand/epidemiology
3.Probability of Antibody Formation against Circumsporozoite Protein of Plasmodium vivax among Korean Malaria Patients.
Ho Woo NAM ; Kyoung Ju SONG ; Hye Jin AHN ; Zhaoshou YANG ; Chom Kyu CHONG ; Pyo Yun CHO ; Seong Kyu AHN ; Tong Soo KIM
The Korean Journal of Parasitology 2014;52(2):143-149
To evaluate the seroprevalence against circumsporozoite protein (CSP) of Plasmodium vivax in sera of Korean patients, the central repeating domain (CRD) of CSP was cloned and analyzed. From the genomic DNA of patient's blood, 2 kinds of CSPs were identified to belong to a VK210 type, which is the dominant repeating of GDRA(D/A)GQPA, and named as PvCSPA and PvCSPB. Recombinantly expressed his-tagged PvCSPA or PvCSPB in Escherichia coli reacted well against sera of patients in western blot, with the detecting rate of 47.9% (58/121), which included 15 cases positive for PvCSPA, 6 cases positive for PvCSPB, and 37 cases for both. The mixture of PvCSPA and PvCSPB was loaded to a rapid diagnostic test kit (RDT) and applied with the same set of patient sera, which resulted in detection rates of 57.0% (69/121). When the protein sequences of PvCSPA were compared with those of P. vivax in endemic regions of India and Uganda, they were compatibly homologous to PvCSPA with minor mutations. These results suggested that the recombinant PvCSPA and PvCSPB loaded RDT may be a milestone in latent diagnosis which has been a hot issue of domestic malaria and important for radical therapy in overlapped infections with P. falciparum in tropical and subtropical areas. During the biological process of malarial infection, exposure of CSP to antigen-antibody reaction up to 57.0% is the first report in Korea.
Amino Acid Sequence
;
Antibodies, Protozoan/*blood/immunology
;
Antibody Formation
;
Antigens, Protozoan/immunology
;
Base Sequence
;
Humans
;
India
;
Malaria, Vivax/*diagnosis/*epidemiology/immunology
;
Merozoite Surface Protein 1/genetics/*immunology
;
Plasmodium vivax/genetics/immunology
;
Protozoan Proteins/genetics/*immunology
;
Reagent Kits, Diagnostic
;
Recombinant Proteins/diagnostic use/immunology
;
Republic of Korea/epidemiology
;
Sequence Analysis, DNA
;
Seroepidemiologic Studies
;
Uganda